Why the study?
Does remifentanil infusion provide stable hemodynamics and rapid recovery in children with congenital heart disease undergoing cardiac catheterization?
Population
30 children (aged 1.5-20 months) with congenital heart disease undergoing cardiac catheterization
Comparison
Continuous infusion of 0.3 microg/kg/min… vs Continuous infusion of 0.2 microg/kg/min…
Design
RCT, randomized, double-blind
Follow-up
10 min after extubation
Authors
Loading...
Supports remifentanil for rapid recovery with hemodynamic stability during pediatric cardiac catheterization; extends RCT evidence to congenital heart disease.
Does remifentanil infusion provide stable hemodynamics and rapid recovery in children with congenital heart disease undergoing cardiac catheterization?
Both 0.2 and 0.3 microg/kg/min doses of remifentanil provide stable hemodynamics and rapid recovery during cardiac catheterization in children with congenital heart disease.
Foubert et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: